Connor, Clark & Lunn Investment Management Ltd. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 48 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$61,000
+306.7%
51,580
+191.7%
0.00%
Q1 2020$15,000
-11.8%
17,685
+1.4%
0.00%
Q4 2019$17,000
-34.6%
17,435
-30.9%
0.00%
Q3 2019$26,000
-55.2%
25,244
-21.5%
0.00%
Q2 2019$58,000
-31.8%
32,169
-28.9%
0.00%
-100.0%
Q1 2019$85,000
+142.9%
45,232
+54.2%
0.00%
Q4 2018$35,000
-67.3%
29,324
-25.8%
0.00%
-100.0%
Q3 2018$107,000
+148.8%
39,524
+73.9%
0.00%
Q2 2018$43,000
-95.6%
22,724
-96.4%
0.00%
-100.0%
Q2 2017$983,000
-54.4%
625,865
-6.3%
0.01%
-57.1%
Q1 2017$2,158,000
+122.9%
668,040
-6.8%
0.01%
+100.0%
Q4 2016$968,000
-10.7%
717,075
+3.2%
0.01%
-12.5%
Q3 2016$1,084,000
+25.2%
694,875
+6.7%
0.01%
+33.3%
Q2 2016$866,000
-74.0%
651,275
+3.2%
0.01%
-76.9%
Q1 2016$3,327,000
-27.7%
631,275
+7.7%
0.03%
-31.6%
Q4 2015$4,601,000
+13.1%
586,150
+21.8%
0.04%
+15.2%
Q3 2015$4,068,000
+477.0%
481,375
+647.5%
0.03%
+450.0%
Q2 2015$705,000
+4.0%
64,400
+32.8%
0.01%0.0%
Q1 2015$678,000
-2.6%
48,500
+17.7%
0.01%0.0%
Q4 2014$696,00041,2000.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders